After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, ...

Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

Key Takeaways BioNTech is buying fellow German firm CureVac for approximately $1.25 billion as the COVID-19 vaccine maker ...

Conflicting recommendations from Trump administration health officials have left health experts, vaccine makers and insurers ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

Kennedy on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this ...

COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants ...

BERLIN — Germany's BioNTech has signed a deal to acquire its former Covid-19 vaccine competitor CureVac for around $1.25 billion (€1.08 billion), the companies announced today. Both biotechs are ...

Health Secretary Robert F. Kennedy Jr. is upending the vaccine advisory committee. It could cost consumers more.

The unusual collaboration between Chinese vaccine researchers and neuroscientists raises questions about how early China knew about COVID-19’s neurological symptoms, which are unusual for these types ...